Skip to main content

Ikjot Singh Sohal

Title: Assistant Professor

Department: Biological Sciences

College: College of Science

Curriculum Vitae

Curriculum Vitae Link

Education

  • PhD, University of Massachusetts Lowell, 2018
    Major: Biomedical Engineering and Biotechnology

Current Scheduled Teaching

BIOC 4570.001Biochemistry and Molecular Biology of the GeneSpring 2026 Syllabus
BIOC 5340.001Biochemistry and Molecular Biology of the GeneSpring 2026
BIOL 4570.001Biochemistry and Molecular Biology of the GeneSpring 2026 Syllabus
BIOL 5340.001Biochemistry and Molecular Biology of the GeneSpring 2026
BIOL 6940.736Individual ResearchSpring 2026

Previous Scheduled Teaching

No previous courses scheduled.

Published Intellectual Contributions

    Book Chapter

  • Liu, X., Zhang, B., Sohal, I., Bello, D., Chen, H. (2019). Is “nano safe to eat or not”? A review of the state-of-the art in soft engineered nanoparticle (sENP) formulation and delivery in foods. Advances in Food and Nutrition Research. 299-335. Elsevier. https://doi.org/10.1016/bs.afnr.2019.03.004
  • Conference Proceeding

  • Mevaa, I.T., Abdelaal, A.M., Sohal, I., Iyer, S.G., Sudarshan, K., Kothandaraman, H., Landman, N.A., Low, P.S., Kasinski, A. (2025). Abstract 1864: Folate-mediated delivery of tumor-suppressive miRNA-34a to treat osteosarcoma. Other. 85 (8_Supplement_1) 1864-1864. https://doi.org/10.1158/1538-7445.AM2025-1864
  • Waiker, D.K., Abdelaal, A.M., Iyer, S.G., Sohal, I., Orellana, E.A., Sudarshan, K., Ozcan, K.E., dos Santos, A.P., Low, P.S., Kasinski, A.L. (2025). Abstract 6700: Ligand-directed delivery of chemically modified miR-34a to prostate cancer: enhanced targeting and extended pharmacokinetics. Other. 85 (8_Supplement_1) 6700-6700. https://doi.org/10.1158/1538-7445.AM2025-6700
  • Piltan, S., Hasan, H., Sohal, I., Pandey, A., Urdaneta, D., Lanman, N., Utturkar, S., Kasinski, A. (2025). Abstract 1192: Selective sorting of tumor suppressive and oncogenic miRNAs into extracellular vesicles: Implications for cancer progression. Other. http://dx.doi.org/10.1158/1538-7445.am2025-1192
  • Sohal, I., Sydney Shaw, N..., Lauren Meeks, N..., Andrea Kasinski, L. (2025). Abstract 925: Golgi-derived extracellular vesicles lack conventional tetraspanins and mediate immune evasion in cancer. Other. http://dx.doi.org/10.1158/1538-7445.am2025-925
  • Sohal, I., Shaw, S.N., Kasinski, A.L. (2023). Abstract 322: Electron microscopy using electron dense genetic tag elucidates novel extracellular vesicle biogenesis in non-small cell lung cancer. Other. 83 (7_Supplement) 322-322. https://doi.org/10.1158/1538-7445.AM2023-322
  • Hasan, H., Lanman, N.A., Utturkar, S., Jauch, J.J., Sohal, I., Soto-Vargas, Z., Kasinski, A.L. (2023). Abstract 3761: Mediators of RNA sorting and export in non-small cell lung cancer derived extracellular vesicles. Other. 83 (7_Supplement) 3761-3761. https://doi.org/10.1158/1538-7445.AM2023-3761
  • Iyer, S.G., Abdelaal, A.M., Sohal, I., Kasireddy, S.R., Kasinski, A.L. (2023). Abstract 3782: Targeting cancer cells using folate conjugated to a fully modified version of miR-34a (FolamiR-34a) to produce enhanced and sustained anti-tumor activity. Other. 83 (7_Supplement) 3782-3782. https://doi.org/10.1158/1538-7445.AM2023-3782
  • Sohal, I., Abdelaal, A.M., Kasinski, A.L. (2022). Determining the intracellular fate of ligand-conjugated therapeutics using nanogold labeling. Other. https://publons.com/wos-op/publon/57616566/
  • Abdelaal, A.M., Kasireddy, S., Sohal, I., Low, P.S., Kasinski, A.L. (2022). Efficient targeting of prostate cancer using ligand conjugated and chemically modified tumor suppressive miRNA. Other. https://publons.com/wos-op/publon/57616563/
  • Vargas, Z.M., Sohal, I., Hasan, H., Arteaga, D., Kasinski, A.L. (2022). Abstract 1581: Uncovering mechanisms of biogenesis and secretion of small extracellular vesicles in non small cell lung cancer (NSCLC). Other. 82 (12_Supplement) 1581-1581. American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2022-1581
  • Journal Article

  • Shreyas Iyer, G..., Sohal, I., Andrea Kasinski, L. (2025). Redesigning miR-34a: structural and chemical advances in the therapeutic development of an miRNA anti-cancer agent. Other. https://doi.org/10.1042/BST20253010
  • Abdelaal, A.M., Sohal, I., Iyer, S.G., Sudarshan, K., Orellana, E.A., Ozcan, K.E., Dos Santos, A.P., Low, P.S., Kasinski, A.L. (2024). Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent.. Other. 35 (2) 102193.
  • Ahmed Abdelaal, M..., Sohal, I., Iyer, S., Sudarshan, K., Kothandaraman, H., Nadia Lanman, A..., Philip Low, S..., Andrea Kasinski, L. (2023). A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy. Oncogene. https://doi.org/10.1038/s41388-023-02801-8
  • Dar, M.S., Mensah, I.K., He, M., McGovern, S., Sohal, I., Whitlock, H.C., Bippus, N.E., Ceminsky, M., Emerson, M.L., Tan, H.J., Hall, M.C., Gowher, H. (2023). Dnmt3bas coordinates transcriptional induction and alternative exon inclusion to promote catalytically active Dnmt3b expression. Other. 42 (7) 112863. Elsevier BV. https://doi.org/10.1016/j.celrep.2023.112863
  • Sohal, I., Kasinski, A.L. (2023). Emerging diversity in extracellular vesicles and their roles in cancer.. Frontiers in Oncology. 13 1167717.
  • Kaur, J., Sohal, I., Singh, H., Gupta, N.K., Sehrawat, S., Puri, S., Bello, D., Khatri, M. (2022). Toxicity screening and ranking of diverse engineered nanomaterials using established hierarchical testing approaches with a complementary in vivo zebrafish model. Other. 9 (8) 2726-2749. Royal Society of Chemistry (RSC). https://doi.org/10.1039/d2en00265e
  • Pal, A.S., Agredo, A., Lanman, N.A., Son, J., Sohal, I., Bains, M., Li, C., Clingerman, J., Gates, K., Kasinski, A.L. (2022). Loss of KMT5C Promotes EGFR Inhibitor Resistance in NSCLC via LINC01510-Mediated Upregulation of MET. Other. 82 (8) 1534-1547. American Association for Cancer Research (AACR). https://doi.org/10.1158/0008-5472.can-20-0821
  • Hasan, H., Sohal, I., Soto-Vargas, Z., Byappanahalli, A.M., Humphrey, S.E., Kubo, H., Kitdumrongthum, S., Copeland, S., Tian, F., Chairoungdua, A., Kasinski, A.L. (2022). Extracellular vesicles released by non-small cell lung cancer cells drive invasion and permeability in non-tumorigenic lung epithelial cells. Scientific Reports. 12 (1) Springer Science and Business Media LLC. https://doi.org/10.1038/s41598-022-04940-6
  • Sohal, I., DeLoid, G.M., O'Fallon, K.S., Gaines, P., Demokritou, P., Bello, D. (2020). Effects of ingested food-grade titanium dioxide, silicon dioxide, iron (III) oxide and zinc oxide nanoparticles on an in vitro model of intestinal epithelium: Comparison between monoculture vs. a mucus-secreting coculture model. Other. 17 100209. Elsevier BV. https://doi.org/10.1016/j.impact.2020.100209
  • Sohal, I., O’Fallon, K.S., Gaines, P., Demokritou, P., Bello, D. (2018). Ingested engineered nanomaterials: state of science in nanotoxicity testing and future research needs. Particle and Fibre Toxicology. 15 (1) Springer Science and Business Media LLC. https://doi.org/10.1186/s12989-018-0265-1
  • Sohal, I., Cho, Y.K., O’Fallon, K.S., Gaines, P., Demokritou, P., Bello, D. (2018). Dissolution Behavior and Biodurability of Ingested Engineered Nanomaterials in the Gastrointestinal Environment. ACS Nano. 12 (8) 8115-8128. American Chemical Society (ACS). https://doi.org/10.1021/acsnano.8b02978
  • DeLoid, G.M., Sohal, I., Lorente, L.R., Molina, R.M., Pyrgiotakis, G., Stevanovic, A., Zhang, R., McClements, D.J., Geitner, N.K., Bousfield, D.W., Ng, K.W., Loo, S.C., Bell, D.C., Brain, J., Demokritou, P. (2018). Reducing Intestinal Digestion and Absorption of Fat Using a Nature-Derived Biopolymer: Interference of Triglyceride Hydrolysis by Nanocellulose. ACS Nano. 12 (7) 6469-6479. American Chemical Society (ACS). https://doi.org/10.1021/acsnano.8b03074

Contracts, Grants and Sponsored Research

    Grant - Research

  • Sohal, I. (Principal), "Evaluate the role of extracellular vesicles in tumor microenvironment modulation," sponsored by National Institute of Health, Federal, $148500 Funded. (2025 - 2027).
  • Sohal, I., "Indiana CTSI Postdoctoral Challenge for the use of Core Facilities," sponsored by Indiana Clinical & Translational Sciences Institute, State, $5000 Funded. (2023 - 2024).
,
Overall
Summative Rating
Challenge and
Engagement Index
Response Rate

out of 5

out of 7
%
of
students responded
  • Overall Summative Rating (median):
    This rating represents the combined responses of students to the four global summative items and is presented to provide an overall index of the class’s quality. Overall summative statements include the following (response options include a Likert scale ranging from 5 = Excellent, 3 = Good, and 1= Very poor):
    • The course as a whole was
    • The course content was
    • The instructor’s contribution to the course was
    • The instructor’s effectiveness in teaching the subject matter was
  • Challenge and Engagement Index:
    This rating combines student responses to several SPOT items relating to how academically challenging students found the course to be and how engaged they were. Challenge and Engagement Index items include the following (response options include a Likert scale ranging from 7 = Much higher, 4 = Average, and 1 = Much lower):
    • Do you expect your grade in this course to be
    • The intellectual challenge presented was
    • The amount of effort you put into this course was
    • The amount of effort to succeed in this course was
    • Your involvement in course (doing assignments, attending classes, etc.) was
CLOSE